Our
Publications
CADAP
EMCDDA initial report on the new psychoactive substance 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-methylmethcathinone, 3-MMC)
3-MMC is a synthetic cathinone monitored by the EMCDDA as a new psychoactive substance through the European Union Early Warning System since 2012. Based on...
Risk assessment of new psychoactive substances (NPS)
Risk assessment is the second step in the three-step legal framework designed to allow the European Union (EU) to rapidly detect, assess, and respond to...
Prevention toolkit
The EMCDDA Prevention toolkit brings together useful tools and resources for anyone involved in shaping decisions, opinions and policies in Europe in the science-based prevention...
Spotlight on… Drug checking
Drug-checking services provide individuals who use drugs with information on the chemical content of their drugs as well as advice and, sometimes, counselling or brief...
Schools and drugs: health and social responses
This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide. It provides an overview...
Penalties for drug law offences at a glance
On this page you can examine and compare the penalties, or rehabilitative responses, for the core offences of drug use, possession for personal use, and...
EU Drug Markets: In-depth analysis
Illicit drugs are big business. They are one of the main profit-generating activities of organised crime and are estimated to represent around one-fifth of global...
Europe’s emergence as a globally important producer of methamphetamine
The main methamphetamine production sites in the EU are located in the Netherlands, Belgium, and Czechia and neighbouring countries (see Figure Location of sites related...
